Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions

Front Immunol. 2022 Nov 22:13:1091668. doi: 10.3389/fimmu.2022.1091668. eCollection 2022.

¹ Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
² QVQ Holding BV, Utrecht, Netherlands.
³ Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
⁴ Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, United States.
⁵ Department of Biology, Faculty of Sciences, Utrecht University, Utrecht, Netherlands.
⁶ VerLin BV, Utrecht, Netherlands.
⁷ Department of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.893648.].

Keywords: Fc fusion; Fc-mediated effector functions; HIV-1; nanobodies; neutralization.